We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-0.25%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
-$6.3M
(-2.8%)
Cap. Flow
+$7.95M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
11.93%
Holding
763
New
327
Increased
77
Reduced
54
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.61M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.35M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$2.15M |
| 4 |
Teck Resources
TECK
|
+$2.12M |
| 5 |
BlackRock Health Sciences Trust II
BMEZ
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$3.72M |
| 2 |
Cintas
CTAS
|
+$3.03M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
+$2.87M |
| 4 |
Verizon
VZ
|
+$2.3M |
| 5 |
Veeva Systems
VEEV
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.88% |
| 2 | Financials | 13.01% |
| 3 | Technology | 12.25% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Rezolute
RZLT
$451M
| $137K | 0.06% |
47,301
+15,890
| +51% | +$69.2K |
|
402
SunCoke Energy
SXC
$799M
| $137K | 0.06% |
+14,870
| New | +$143K |
|
403
PennantPark Floating Rate Capital
PFLT
$734M
| $136K | 0.06% |
+12,186
| New | +$136K |
|
404
Kelly Services Class A
KELYA
$544M
| $135K | 0.06% |
10,264
-7,435
| -42% | -$102K |
|
|
SEMR
405
DELISTED
Semrush
SEMR
| $134K | 0.06% |
+14,339
| New | +$196K |
|
406
Future Fuel
FF
$226M
| $132K | 0.06% |
+33,769
| New | +$162K |
|
407
Clover Health Investments
CLOV
$2.41B
| $131K | 0.06% |
+36,515
| New | +$147K |
|
408
Vir Biotechnology
VIR
$1.5B
| $127K | 0.06% |
+19,626
| New | +$174K |
|
409
Taboola.com
TBLA
$1.12B
| $121K | 0.06% |
+41,093
| New | +$140K |
|
|
NFBK
410
DELISTED
Northfield Bancorp
NFBK
| $121K | 0.06% |
+11,089
| New | +$128K |
|
|
SRTA
411
Strata Critical Medical Inc
SRTA
$525M
| $120K | 0.05% |
+43,868
| New | +$157K |
|
412
Cullinan Oncology
CGEM
$1.18B
| $119K | 0.05% |
+15,746
| New | +$151K |
|
|
ITOS
413
DELISTED
iTeos Therapeutics
ITOS
| $119K | 0.05% |
+19,889
| New | +$146K |
|
414
Goldman Sachs BDC
GSBD
$1.1B
| $118K | 0.05% |
10,143
-21,316
| -68% | -$267K |
|
415
Quad
QUAD
$507M
| $117K | 0.05% |
21,465
+2,116
| +11% | +$13.4K |
|
416
1-800-Flowers.com
FLWS
$255M
| $117K | 0.05% |
+19,825
| New | +$146K |
|
417
Domo
DOMO
$189M
| $112K | 0.05% |
+14,394
| New | +$115K |
|
418
DocGo
DCGO
$56.8M
| $110K | 0.05% |
+41,828
| New | +$168K |
|
419
Cytek Biosciences
CTKB
$606M
| $107K | 0.05% |
+26,640
| New | +$138K |
|
420
NexGen Energy
NXE
$6.91B
| $106K | 0.05% |
23,718
-6,643
| -22% | -$39.3K |
|
421
Garrett Motion
GTX
$5.41B
| $102K | 0.05% |
+12,195
| New | +$113K |
|
422
Arvinas
ARVN
$588M
| $102K | 0.05% |
+14,463
| New | +$227K |
|
423
RPC Inc
RES
$1.36B
| $101K | 0.05% |
+18,327
| New | +$109K |
|
424
Rayonier Advanced Materials
RYAM
$593M
| $96.8K | 0.04% |
+16,829
| New | +$118K |
|
|
TERN
425
DELISTED
Terns Pharmaceuticals
TERN
| $91.2K | 0.04% |
33,027
+17,571
| +114% | +$71.8K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Oxford Asset Management held 763 positions worth $219M, down 2.8% from $225M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Oxford Asset Management deployed $7.95M of net new capital in Q1 2025, opening 327 new positions and adding to 77 existing holdings. Its largest new stake was Oracle: 16,001 shares worth $2.24M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Cintas, an estimated $3.03M trimmed.
- Oxford Asset Management's largest Q1 2025 buy was Oracle: 16,001 shares worth $2.24M.
- Oxford Asset Management added most to NEVRO CORP. in Q1 2025, an estimated $2.05M increase.
- Oxford Asset Management's biggest Q1 2025 reduction was Cintas, cutting an estimated $3.03M.
- Oxford Asset Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $3.72M.
- Oxford Asset Management's ten largest holdings make up 12% of its $219M portfolio in Q1 2025.
- Oxford Asset Management opened 327 new positions and closed 297 in Q1 2025.
- Oxford Asset Management's portfolio value fell 2.8% quarter-over-quarter to $219M.
Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.